Chuan-Yuan Li

Title: Chuan-Yuan Li: Innovator in Cancer Treatment

Introduction

Chuan-Yuan Li is a prominent inventor based in Englewood, CO, who has made significant contributions to the field of cancer treatment. With a total of 5 patents, his work focuses on innovative methods for enhancing the effectiveness of immune therapies in oncology.

Latest Patents

Li's latest patents include groundbreaking research on biomarkers associated with checkpoint immune therapy. This patent outlines methods for treating cancer by administering immune checkpoint blockade (ICB) therapy to patients whose cancer exhibits specific mutations in genes linked to ICB responsiveness. Another notable patent involves compositions and methods for treating cancer characterized by PCSK9 expression, which details a method for administering a therapeutically effective amount of a PCSK9 inhibitor, potentially in conjunction with an immune checkpoint inhibitor.

Career Highlights

Chuan-Yuan Li has established himself as a key figure in cancer research, particularly through his association with Duke University. His innovative approaches to cancer treatment have garnered attention and respect within the scientific community.

Collaborations

Li has collaborated with esteemed colleagues such as Mark W Dewhirst and Qian Huang, further enhancing the impact of his research through shared expertise and insights.

Conclusion

Chuan-Yuan Li's contributions to cancer treatment through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in cancer therapies, offering hope for improved patient outcomes.